Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Use of Compression Bandages in the Prevention of Post-mastectomy Lymphoceles

NCT04819542 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2021-08-16
Last updated
2026-06-01

Condition(s) studied

Lymphocele

Investigational drug(s) / intervention(s)

BandageNo bandage

Bandage: Bandage

No bandage: No bandage

Study summary

Lymphocele secondary to a mastectomy whether or not associated with a lymph node procedure (sentinel lymph node or axillary dissection) is an almost systematic consequence observed in the postoperative situation in this type of surgery.

This can be the source of pain, skin complications, and infection with a significant impact on the length of hospitalization for patients treated for breast cancer.

There is no consensus regarding the management of lymphocele. The placement of a compression bandage after mastectomy and / or axillary dissection would allow a more efficient and rapid reduction of the lymphocele and a reduction in recurrences.

This would make it possible to reduce the duration of the wearing of the drain, which determines the length of hospitalization and reduce the recurrence of lymphoceles, the punctures of which can be one of the risk factors for secondary lymphedema.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients over 18 years old, * Undergoing mastectomy-type surgery with or without axillary dissection for breast cancer * Affiliated with a health insurance plan Exclusion Criteria: * Recurrence of breast cancer, * Mastectomy with RMI (immediate breast reconstruction) at the same time of operation * Anticoagulant treatment at curative dose * Arteritis obliterans of the upper limbs, * Other cancer during treatment, * Decompensated heart failure, * Acute infectious episode (cellulitis, erysipelas, lymphangitis) * Acute deep vein thrombosis upper limb ipsilateral to mastectomy, * Cutaneous atrophy of the upper limb, * Bullous dermatoses, * Hyperalgesia of the shoulder * Inability to submit to the constraints of the protocol, * Impossibility for the patient to achieve self-restraint at the thoracic level * Pregnancy, * Feeding with milk * BMI\> 35 * Adult protected by law (guardianship, curatorship and safeguard of justice). * Anyone who is not in a position to give their consent in writing

Primary outcome measure(s)

  • Proportion in percentage of patients treated successfully — 6 months
    Provide an estimate of the proportion of patients treated successfully (success rate defined by the absence of lymphocele on D4 post mastectomy) in two groups of patients (drain + compression bandage vs drain without compression bandage).

Trial sites (1)

FacilityCityRegionStatus
University Hospital Toulouse France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04819542 on ClinicalTrials.gov ↗ ← All trials in France